Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Neuroscience Letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 14625020
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ligands of the peroxisome proliferator‐activated receptors (PPAR‐γ and PPAR‐α) reduce myocardial infarct size

  2002cited by this paper
• Pioglitazone, a Peroxisome Proliferator-Activated Receptor-&ggr; Agonist, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

  2002cited by this paper
• Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia.

  2001cited by this paper
• In Vivo Myocardial Protection From Ischemia/Reperfusion Injury by the Peroxisome Proliferator–Activated Receptor-&ggr; Agonist Rosiglitazone

  2001cited by this paper
• Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice

  2001cited by this paper
• Reduction in Stroke With Gemfibrozil in Men With Coronary Heart Disease and Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT)

  2001cited by this paper
• Biological effects of resveratrol.

  2000cited by this paper
• Feedback control of cyclooxygenase-2 expression through PPARgamma.

  2000cited by this paper
• Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells.

  1999cited by this paper
• The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury.

  1999cited by this paper
• PPAR gamma is required for placental, cardiac, and adipose tissue development.

  1999cited by this paper
• The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.

  1998cited by this paper
• Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

  1998cited by this paper
• Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

  1998cited by this paper
• PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.

  1998cited by this paper
• Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs.

  1997cited by this paper
• Wine as a biological fluid: History, production, and role in disease prevention

  1997cited by this paper
• An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

  1995cited by this paper
• Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

  1995cited by this paper
• Determinants of target gene specificity for steroid/thyroid hormone receptors.

  1989cited by this paper
• Effects of stilbenes on arachidonate metabolism in leukocytes.

  1985cited by this paper

• Potentials of peroxisome proliferator-activated receptor (PPAR) α, β/δ, and γ: An in-depth and comprehensive review of their molecular mechanisms, cellular Signalling, immune responses and therapeutic implications in multiple diseases.

  2025cites this paper
• Role of peroxisome proliferator-activated receptor alpha in neurodegenerative diseases and other neurological disorders: Clinical application prospects

  2025cites this paper
• Dietary Polyphenols: Review on Chemistry/Sources, Bioavailability/Metabolism, Antioxidant Effects, and Their Role in Disease Management

  2024cites this paper
• Current View on PPAR-α and Its Relation to Neurosteroids in Alzheimer’s Disease and Other Neuropsychiatric Disorders: Promising Targets in a Therapeutic Strategy

  2024cites this paper
• Anaerobic Glycolysis and Ischemic Stroke: From Mechanisms and Signaling Pathways to Natural Product Therapy.

  2024cites this paper
• Effect and mechanisms of resveratrol in animal models of ischemic stroke: A systematic review and Bayesian meta-analysis

  2023cites this paper
• Cellular Stress Response (Hormesis) in Response to Bioactive Nutraceuticals with Relevance to Alzheimer Disease

  2023cites this paper
• Artichoke (Cynara Scolymus) Methanolic Leaf Extract Alleviates Diethylnitrosamine-Induced Toxicity in BALB/c Mouse Brain: Involvement of Oxidative Stress and Apoptotically Related Klotho/PPARγ Signaling

  2022cites this paper
• How cytosolic compartments play safeguard functions against neuroinflammation and cell death in cerebral ischemia

  2021cites this paper
• The effects of resveratrol supplementation on PPARα, p16, p53, p21 gene expressions, and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: A double‐blind controlled randomized trial

  2021cites this paper
• Resveratrol noncompetitively inhibits glycine receptor-mediated currents in neurons of rat central auditory neurons.

  2021cites this paper
• Resveratrol and related stilbene derivatives induce stress granules with distinct clearance kinetics

  2021cites this paper
• Fenofibrate Protects against Retinal Dysfunction in a Murine Model of Common Carotid Artery Occlusion-Induced Ocular Ischemia

  2021cites this paper
• Oxidative Stress in the Brain: Basic Concepts and Treatment Strategies in Stroke

  2021cites this paper
• Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders

  2021cites this paper
• Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration

  2021cites this paper
• Resveratrol has an Overall Neuroprotective Role in Ischemic Stroke: A Meta-Analysis in Rodents

  2021cites this paper
• Discovering the Protective Effects of Resveratrol on Aflatoxin B1-Induced Toxicity: A Whole Transcriptomic Study in a Bovine Hepatocyte Cell Line

  2021cites this paper
• The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer’s Disease and Other Neurodegenerative Disorders

  2020cites this paper
• Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review

  2020cites this paper
• Phytochemical drug candidates for the modulation of peroxisome proliferator‐activated receptor γ in inflammatory bowel diseases

  2020cites this paper
• Repairing blood-CNS barriers: Future therapeutic approaches for neuropsychiatric disorders.

  2020cites this paper
• Neurovascular protection by peroxisome proliferator-activated receptor α in ischemic stroke.

  2020cites this paper
• Red cabbage (Brassica oleracea L.) extract reverses lipid oxidative stress in rats.

  2020cites this paper
• The Fenofibrate Effect on Genotoxicity in Brain and Liver and on the Expression of Genes Regulating Fatty Acids Metabolism of Mice

  2019cites this paper
• In Silico Discovery of Resveratrol Analogues as Potential Agents in Treatment of Metabolic Disorders.

  2019cites this paper
• The effect of resveratrol supplementation on the expression levels of factors associated with cellular senescence and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomised clinical trial

  2019cites this paper
• PPAR Ligands Containing Stilbene Scaffold.

  2019cites this paper
• Resveratrol Regulates BDNF, trkB, PSA-NCAM, and Arc Expression in the Rat Cerebral Cortex after Bilateral Common Carotid Artery Occlusion and Reperfusion

  2019cites this paper
• Effects of Resveratrol Postconditioning on Cerebral Ischemia in mice: Role of the Sirtuin-1 (SIRT1) Pathway.

  2019cites this paper
• The Effect of Resveratrol Supplementation on Cardio‐Metabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized, Double‐Blind Controlled Trial

  2019cites this paper
• Resveratrol Modulates Desaturase Expression and Fatty Acid Composition of Cultured Hepatocytes

  2018cites this paper
• Preventive Effects of Resveratrol on Endocannabinoid System and Synaptic Protein Modifications in Rat Cerebral Cortex Challenged by Bilateral Common Carotid Artery Occlusion and Reperfusion

  2018cites this paper
• Molecular Actions of PPARα in Lipid Metabolism and Inflammation.

  2018cites this paper
• Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights

  2018cites this paper
• Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury

  2018cites this paper
• PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation

  2017cites this paper
• Peroxisome proliferator‐activated receptor α ligands and modulators from dietary compounds: Types, screening methods and functions

  2017cites this paper
• Peripheral and Cerebral Resistance Arteries in the Spontaneously Hypertensive Heart Failure Rat: Effects of Stilbenoid Polyphenols

  2017cites this paper
• Collagen peptide ingestion alters lipid metabolism-related gene expression and the unfolded protein response in mouse liver.

  2017cites this paper
• The potential of natural products for targeting PPARα

  2017cites this paper
• Fenofibrate exerts protective effects against gentamicin-induced toxicity in cochlear hair cells by activating antioxidant enzymes

  2017cites this paper
• Resveratrol protects against ICV collagenase-induced neurobehavioral and biochemical deficits

  2017cites this paper
• Multifaceted Mechanisms of WY-14643 to Stabilize the Blood-Brain Barrier in a Model of Traumatic Brain Injury

  2017cites this paper
• Fatty Acid Profile Is Modulated by Dietary Resveratrol in Rainbow Trout (Oncorhynchus mykiss)

  2017cites this paper
• Partridgeberry polyphenols protect rat primary cortical neurons from oxygen–glucose deprivation–reperfusion-induced injury via suppression of inflammatory adipokines and regulation of HIF-1α and PPARγ

  2016cites this paper
• Protective effect of resveratrol against neuronal damage following transient global cerebral ischemia in mice.

  2016cites this paper
• Resveratrol improves salivary dysfunction in a non-obese diabetic (NOD) mouse model of Sjögren’s syndrome

  2016cites this paper
• Effects of pterostilbene and resveratrol on brain and behavior.

  2015cites this paper
• Resveratrol Targets in Inflammation.

  2015cites this paper
• The pharmacology of resveratrol in animals and humans.

  2015cites this paper
• Food Components Modulate Obesity and Energy Metabolism via the Transcriptional Regulation of Lipid-Sensing Nuclear Receptors.

  2015cites this paper
• Common pathways in health benefit properties of RSV in cardiovascular diseases, cancers and degenerative pathologies.

  2015cites this paper
• Resveratrol neuroprotection in stroke and traumatic CNS injury.

  2015cites this paper
• Resveratrol prevents renal lipotoxicity in high-fat diet-treated mouse model through regulating PPAR-α pathway

  2015cites this paper
• The 4′-Hydroxyl Group of Resveratrol Is Functionally Important for Direct Activation of PPARα

  2015cites this paper
• Malibatol A regulates microglia M1/M2 polarization in experimental stroke in a PPARγ-dependent manner

  2015cites this paper
• Resveratrol Does Not Influence Metabolic Risk Markers Related to Cardiovascular Health in Overweight and Slightly Obese Subjects: A Randomized, Placebo-Controlled Crossover Trial

  2015cites this paper
• Estrogen receptor-mediated resveratrol actions on blood-brain barrier of ovariectomized mice.

  2015cites this paper
• Novel PPAR Pan Agonist, ZBH Ameliorates Hyperlipidemia and Insulin Resistance in High Fat Diet Induced Hyperlipidemic Hamster

  2014cites this paper
• Resveratrol and Its Metabolites Bind to PPARs

  2014cites this paper
• Effects of peroxisome proliferator-activated receptor γ in simvastatin antiplatelet activity: influences on cAMP and mitogen-activated protein kinases.

  2014cites this paper
• Resveratrol inhibits the phosphatidylinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line

  2014cites this paper
• Dietary and Nutritional Manipulation of the Nuclear Transcription Factors Peroxisome Proliferator-Activated Receptor and Sterol Regulatory Element-Binding Proteins As a Tool for Reversing the Primary Diseases of Premature Death and Delaying Aging

  2014cites this paper
• Resveratrol and stroke: from chemistry to medicine.

  2014cites this paper
• Activation of peroxisome proliferator-activated receptor β/δ attenuates acute ischemic stroke on middle cerebral ischemia occlusion in rats.

  2014cites this paper
• Resveratrol protects RPE cells from sodium iodate by modulating PPARα and PPARδ.

  2014cites this paper
• Effects of the PPAR-α Agonist Fenofibrate on Acute and Short-Term Consequences of Brain Ischemia

  2014cites this paper
• Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.

  2014cites this paper
• Mechanism of the anti-platelet effect of natural bioactive compounds: Role of peroxisome proliferator-activated receptors activation

  2014cites this paper
• Mechanism of antiplatelet action of hypolipidemic, antidiabetic and antihypertensive drugs by PPAR activation: PPAR agonists: new antiplatelet agents.

  2014cites this paper
• Adaptive Cellular Stress Pathways as Therapeutic Targets of Dietary Phytochemicals: Focus on the Nervous System

  2014cites this paper
• Regulatory mechanisms of cAMP levels as a multiple target for antiplatelet activity and less bleeding risk.

  2014cites this paper
• Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases.

  2013cites this paper
• Palmitoylethanolamide Is a Disease-Modifying Agent in Peripheral Neuropathy: Pain Relief and Neuroprotection Share a PPAR-Alpha-Mediated Mechanism

  2013cites this paper
• Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities.

  2013cites this paper
• Resveratrol Inhibits CD4+ T Cell Activation by Enhancing the Expression and Activity of Sirt1

  2013cites this paper
• Relationship between Platelet PPARs, cAMP Levels, and P-Selectin Expression: Antiplatelet Activity of Natural Products

  2013cites this paper
• PPARs: a potential target for a disease-modifying strategy in stroke.

  2013cites this paper
• Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models.

  2013cites this paper
• Resveratrol derivatives: a patent review (2009 – 2012)

  2013cites this paper
• Up-regulation of endothelial nitric oxide synthase (eNOS), silent mating type information regulation 2 homologue 1 (SIRT1) and autophagy-related genes by repeated treatments with resveratrol in human umbilical vein endothelial cells

  2013influential citation
• Pleiotropic effects of PPARγ agonist on hemostatic activation in type 2 diabetes mellitus.

  2013cites this paper
• Phytoalexins, miRNAs and Breast Cancer: A Review of Phytochemical-mediated miRNA Regulation in Breast Cancer

  2013cites this paper
• PPAR-α as a key nutritional and environmental sensor for metabolic adaptation.

  2013cites this paper
• Gemfibrozil pretreatment proved protection against acute restraint stress-induced changes in the male rats' hippocampus.

  2013cites this paper
• Neuroprotective effect of resveratrol against prenatal stress induced cognitive impairment and possible involvement of Na(+), K(+)-ATPase activity.

  2013cites this paper
• Natural Polyphenols Inhibit Lysine-Specific Demethylase-1 in vitro.

  2013cites this paper
• Plant Oils and Cardiometabolic Risk Factors: The Role of Genetics

  2012cites this paper
• Pleiotropic Protective Effects of Phytochemicals in Alzheimer's Disease

  2012cites this paper
• Resveratrol in cardiovascular disease: what is known from current research?

  2012cites this paper
• Are sirtuins viable targets for improving healthspan and lifespan?

  2012cites this paper
• Potential neuroprotective effects of oxyresveratrol against traumatic injury.

  2012cites this paper
• Recent advances in the study on resveratrol.

  2012cites this paper
• Long-term resveratrol consumption protects ovariectomized rats chronically treated with D-galactose from developing memory decline without effects on the uterus.

  2012cites this paper
• Endothelial Cells and Astrocytes: A Concerto en Duo in Ischemic Pathophysiology

  2012cites this paper
• Resveratrol in Cholesterol Metabolism and Atherosclerosis

  2012cites this paper
• Acute Resveratrol Treatment Modulates Multiple Signaling Pathways in the Ischemic Brain

  2012cites this paper
• The Synergic Effect of Regular Exercise and Resveratrol on Kainate-Induced Oxidative Stress and Seizure Activity in Mice

  2012cites this paper
• Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells.

  2012cites this paper